Your browser doesn't support javascript.
loading
Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants.
Leman, Raphaël; Tubeuf, Hélène; Raad, Sabine; Tournier, Isabelle; Derambure, Céline; Lanos, Raphaël; Gaildrat, Pascaline; Castelain, Gaia; Hauchard, Julie; Killian, Audrey; Baert-Desurmont, Stéphanie; Legros, Angelina; Goardon, Nicolas; Quesnelle, Céline; Ricou, Agathe; Castera, Laurent; Vaur, Dominique; Le Gac, Gérald; Ka, Chandran; Fichou, Yann; Bonnet-Dorion, Françoise; Sevenet, Nicolas; Guillaud-Bataille, Marine; Boutry-Kryza, Nadia; Schultz, Inès; Caux-Moncoutier, Virginie; Rossing, Maria; Walker, Logan C; Spurdle, Amanda B; Houdayer, Claude; Martins, Alexandra; Krieger, Sophie.
Afiliación
  • Leman R; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France. r.leman@baclesse.unicancer.fr.
  • Tubeuf H; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France. r.leman@baclesse.unicancer.fr.
  • Raad S; Université Caen-Normandie, Caen, France. r.leman@baclesse.unicancer.fr.
  • Tournier I; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Derambure C; Interactive Biosoftware, Rouen, France.
  • Lanos R; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Gaildrat P; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Castelain G; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Hauchard J; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Killian A; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Baert-Desurmont S; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Legros A; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Goardon N; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Quesnelle C; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Ricou A; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Castera L; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Vaur D; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Le Gac G; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Ka C; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Fichou Y; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Bonnet-Dorion F; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Sevenet N; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Guillaud-Bataille M; Laboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, Caen, France.
  • Boutry-Kryza N; Inserm U1245, Normandy Center for Genomic and Personalized Medicine, Rouen, UNIROUEN, Normandy University, Caen, France.
  • Schultz I; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
  • Caux-Moncoutier V; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
  • Rossing M; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
  • Walker LC; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, Bordeaux, France.
  • Spurdle AB; Inserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, Bordeaux, France.
  • Houdayer C; Service de Génétique, Institut Gustave Roussy, Villejuif, France.
  • Martins A; Lyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, Lyon, France.
  • Krieger S; Laboratoire d'Oncogénétique, Centre Paul Strauss, Strasbourg, France.
BMC Genomics ; 21(1): 86, 2020 Jan 28.
Article en En | MEDLINE | ID: mdl-31992191
ABSTRACT

BACKGROUND:

Branch points (BPs) map within short motifs upstream of acceptor splice sites (3'ss) and are essential for splicing of pre-mature mRNA. Several BP-dedicated bioinformatics tools, including HSF, SVM-BPfinder, BPP, Branchpointer, LaBranchoR and RNABPS were developed during the last decade. Here, we evaluated their capability to detect the position of BPs, and also to predict the impact on splicing of variants occurring upstream of 3'ss.

RESULTS:

We used a large set of constitutive and alternative human 3'ss collected from Ensembl (n = 264,787 3'ss) and from in-house RNAseq experiments (n = 51,986 3'ss). We also gathered an unprecedented collection of functional splicing data for 120 variants (62 unpublished) occurring in BP areas of disease-causing genes. Branchpointer showed the best performance to detect the relevant BPs upstream of constitutive and alternative 3'ss (99.48 and 65.84% accuracies, respectively). For variants occurring in a BP area, BPP emerged as having the best performance to predict effects on mRNA splicing, with an accuracy of 89.17%.

CONCLUSIONS:

Our investigations revealed that Branchpointer was optimal to detect BPs upstream of 3'ss, and that BPP was most relevant to predict splicing alteration due to variants in the BP area.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Precursores del ARN / Intrones / Empalme del ARN / Sitios de Empalme de ARN Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Genomics Asunto de la revista: GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Precursores del ARN / Intrones / Empalme del ARN / Sitios de Empalme de ARN Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Genomics Asunto de la revista: GENETICA Año: 2020 Tipo del documento: Article País de afiliación: Francia